Bone Biologics Corporation Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.67 | -$0.67 | -$0.67 |
| Q2 2024 | 1 | -$0.60 | -$0.60 | -$0.60 |
| Q3 2024 | 1 | -$0.59 | -$0.59 | -$0.59 |
| Q1 2025 | 1 | -$0.54 | -$0.54 | -$0.54 |
| Q2 2025 | 1 | -$0.51 | -$0.51 | -$0.51 |
| Q3 2025 | 1 | -$0.55 | -$0.55 | -$0.55 |
| Q4 2025 | 1 | -$0.59 | -$0.59 | -$0.59 |
Bone Biologics Corporation Earnings Date And Information
Bone Biologics Corporation last posted its earnings results on Friday, August 9th, 2024. The company reported $-0.67 earnings per share for the quarter, topping analysts' consensus estimates of $-1.39 by $0.72. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Bone Biologics Corporation has generated $-34 earnings per share over the last year ($-34.01 diluted earnings per share) and currently has a price-to-earnings ratio of -0.3. Bone Biologics Corporation has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 19th, 2025 based on prior year's report dates.
Bone Biologics Corporation Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$2.37 | $0 | $0 | ||
| 08/09/2024 | Q2 2024 | -$1.39 | -$0.67 | 0.72 | $0 | $0 |
| 05/14/2024 | Q1 2024 | -$7.60 | -$1.31 | 6.29 | $0 | |
| 02/21/2024 | Q4 2023 | -$3.38 | $0 | |||
| 11/14/2023 | Q3 2023 | -$24.32 | -$4.90 | 19.42 | $0 | |
| 08/14/2023 | Q2 2023 | -$12.00 | -$5.21 | 6.79 | $0 | |
| 05/15/2023 | Q1 2023 | -$360.36 | -$55.20 | 305.16 | $0 | |
| 11/20/2023 | Q4 2022 | $14.63 | $0 | |||
| 11/14/2022 | Q3 2022 | -$60.06 | -$28.23 | 31.83 | $0 | |
| 08/11/2022 | Q2 2022 | -$28.83 | -$10.88 | 17.95 | $0 | |
| 05/13/2022 | Q1 2022 | -$48.05 | -$15.99 | 32.06 | $0 | |
| 03/15/2022 | Q4 2021 | -$0.17 | -$4.12 | -3.95 | $0 | |
| 11/15/2021 | Q3 2021 | -$9.96 | $0 | |||
| 08/16/2021 | Q2 2021 | -$9.62 | $0 | |||
| 05/21/2021 | Q1 2021 | -$35.59 | $0 | |||
| 04/15/2021 | Q4 2020 | -$8.87 | $0 | |||
| 04/15/2021 | Q3 2020 | -$7.71 | $0 | |||
| 04/15/2021 | Q2 2020 | -$7.43 | $0 | |||
| 04/15/2021 | Q1 2020 | -$11.67 | $0 | |||
| 03/27/2020 | Q4 2019 | -$10.39 | $0 |
Bone Biologics Corporation Earnings: Frequently Asked Questions
-
When is Bone Biologics Corporation's earnings date?
Bone Biologics Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 19th, 2025 based off last year's report dates.
-
Did Bone Biologics Corporation beat their earnings estimates last quarter?
In the previous quarter, Bone Biologics Corporation (:BBLG) reported $-0.67 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.39 by $0.72.
-
How can I listen to Bone Biologics Corporation's earnings conference call?
The conference call for Bone Biologics Corporation's latest earnings report can be listened to online.
-
How can I read Bone Biologics Corporation's conference call transcript?
The conference call transcript for Bone Biologics Corporation's latest earnings report can be read online.
-
How much profit does Bone Biologics Corporation generate each year?
Bone Biologics Corporation (:BBLG) has a recorded net income of $0. Bone Biologics Corporation has generated $-34.01 earnings per share over the last four quarters.
-
What is Bone Biologics Corporation's price-to-earnings ratio?
Bone Biologics Corporation (:BBLG) has a price-to-earnings ratio of -0.3 and price/earnings-to-growth ratio is -0.01.
